These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 23065928

  • 1. A fast track to personalized medicine?: whole-genome sequencing may lead to better cancer therapies.
    Nelson B.
    Cancer Cytopathol; 2012 Oct 25; 120(5):283-4. PubMed ID: 23065928
    [No Abstract] [Full Text] [Related]

  • 2. Impact of genomics on personalized cancer medicine.
    Arteaga CL, Baselga J.
    Clin Cancer Res; 2012 Feb 01; 18(3):612-8. PubMed ID: 22298893
    [Abstract] [Full Text] [Related]

  • 3. Progress towards personalized medicine.
    Bates S.
    Drug Discov Today; 2010 Feb 01; 15(3-4):115-20. PubMed ID: 19914397
    [Abstract] [Full Text] [Related]

  • 4. Era of personalized medicine may herald end of soaring cancer costs.
    Keogh B.
    J Natl Cancer Inst; 2012 Jan 04; 104(1):12-3, 16-7. PubMed ID: 22173586
    [No Abstract] [Full Text] [Related]

  • 5. [Personalized treatment of cancer: utopia or chance?].
    Thiel E.
    Dtsch Med Wochenschr; 2010 Sep 04; 135(38):1851. PubMed ID: 20842603
    [No Abstract] [Full Text] [Related]

  • 6. Counterpoint: Data first.
    Golub T.
    Nature; 2010 Apr 01; 464(7289):679. PubMed ID: 20360719
    [No Abstract] [Full Text] [Related]

  • 7. Personalized medicine - the promised land: are we there yet?
    Li C.
    Clin Genet; 2011 May 01; 79(5):403-12. PubMed ID: 21204795
    [Abstract] [Full Text] [Related]

  • 8. Refocusing the war on cancer: the critical role of personalized treatment.
    Potti A, Schilsky RL, Nevins JR.
    Sci Transl Med; 2010 Apr 21; 2(28):28cm13. PubMed ID: 20410527
    [Abstract] [Full Text] [Related]

  • 9. Sequencing set to alter clinical landscape.
    Hayden EC.
    Nature; 2012 Feb 15; 482(7385):288. PubMed ID: 22337027
    [No Abstract] [Full Text] [Related]

  • 10. Will personalized medicine challenge or reify categories of race and ethnicity?
    Rajagopalan R, Fujimura JH.
    Virtual Mentor; 2012 Aug 01; 14(8):657-63. PubMed ID: 23351323
    [No Abstract] [Full Text] [Related]

  • 11. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH.
    Expert Rev Mol Diagn; 2010 Jan 01; 10(1):33-48. PubMed ID: 20014921
    [Abstract] [Full Text] [Related]

  • 12. From genomic landscapes to personalized cancer management-is there a roadmap?
    Swanton C, Caldas C.
    Ann N Y Acad Sci; 2010 Oct 01; 1210():34-44. PubMed ID: 20973797
    [Abstract] [Full Text] [Related]

  • 13. Role of genomics on the path to personalized medicine.
    Tremblay J, Hamet P.
    Metabolism; 2013 Jan 01; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [Abstract] [Full Text] [Related]

  • 14. Personalized medicine: the medicine of tomorrow. Foreword.
    Tremblay-Servier M.
    Metabolism; 2013 Jan 01; 62 Suppl 1():S1. PubMed ID: 23018144
    [No Abstract] [Full Text] [Related]

  • 15. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR, Johnson BE, Sledge GW.
    Clin Cancer Res; 2012 Feb 01; 18(3):619-24. PubMed ID: 22298894
    [Abstract] [Full Text] [Related]

  • 16. Placing bets on biotech.
    Weintraub K.
    Cancer Discov; 2011 Nov 01; 1(6):462. PubMed ID: 22586641
    [No Abstract] [Full Text] [Related]

  • 17. Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.
    Picker A, Jackson DB.
    Expert Rev Mol Diagn; 2011 Jul 01; 11(6):567-77. PubMed ID: 21745011
    [Abstract] [Full Text] [Related]

  • 18. From cancer genomics to precision oncology--tissue's still an issue.
    Cohen RL, Settleman J.
    Cell; 2014 Jun 19; 157(7):1509-14. PubMed ID: 24949964
    [Abstract] [Full Text] [Related]

  • 19. [Economic effects of "molecular" medicine].
    Riemann JF.
    Dtsch Med Wochenschr; 2007 Aug 19; 132(34-35):1740. PubMed ID: 17713881
    [No Abstract] [Full Text] [Related]

  • 20. Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis.
    Tirelli U, Berretta M, Bearz A, Carbone A.
    Eur Rev Med Pharmacol Sci; 2011 Nov 19; 15(11):1355-6. PubMed ID: 22195374
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.